Your browser doesn't support javascript.
loading
Update on Immunotherapy Cardiotoxicity: Checkpoint Inhibitors, CAR T, and Beyond.
Patel, Murti; Hudson, Olivia; Han, Jingnan; Kondapalli, Lavanya; Arora, Garima; Hawi, Riem; Andrikopoulou, Efstathia; Estes, Courtney; Johnson, Abigail M; Lenneman, Carrie.
Afiliación
  • Patel M; University of Alabama at Birmingham (UAB) Heersink School of Medicine, Birmingham, AL, USA.
  • Hudson O; University of Alabama at Birmingham (UAB) Heersink School of Medicine, Birmingham, AL, USA.
  • Han J; University of Alabama at Birmingham (UAB) Heersink School of Medicine, Birmingham, AL, USA.
  • Kondapalli L; University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO, USA.
  • Arora G; University of Alabama at Birmingham (UAB) Heersink School of Medicine, Birmingham, AL, USA.
  • Hawi R; University of Alabama at Birmingham (UAB) Heersink School of Medicine, Birmingham, AL, USA.
  • Andrikopoulou E; University of Alabama at Birmingham (UAB) Heersink School of Medicine, Birmingham, AL, USA.
  • Estes C; University of Alabama at Birmingham (UAB) Heersink School of Medicine, Birmingham, AL, USA.
  • Johnson AM; University of Alabama at Birmingham (UAB) Heersink School of Medicine, Birmingham, AL, USA.
  • Lenneman C; University of Alabama at Birmingham (UAB) Heersink School of Medicine, Birmingham, AL, USA. clenneman@uabmc.edu.
Curr Treat Options Oncol ; 24(11): 1489-1503, 2023 Nov.
Article en En | MEDLINE | ID: mdl-37624557

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Receptores Quiméricos de Antígenos / Cardiopatías / Insuficiencia Cardíaca / Neoplasias Límite: Humans Idioma: En Revista: Curr Treat Options Oncol Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Receptores Quiméricos de Antígenos / Cardiopatías / Insuficiencia Cardíaca / Neoplasias Límite: Humans Idioma: En Revista: Curr Treat Options Oncol Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos